Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2021
Abiomed acquires preCARDIA
Abiomed acquired preCARDIA, a developer of a catheter and controller intended to complement Abiomed's product portfolio. The preCARDIA system was available for investigational use only and was not approved for use outside clinical studies.
2020
FDA authorizes first-in-human feasibility study of Impella ECP
Abiomed announced that the U.S. FDA approved its investigational device exemption application, allowing an early feasibility study and first-in-human trial of the Impella ECP heart pump to proceed. The device is for investigational use only and is not approved for use outside clinical studies.
2020
Abiomed acquires Breethe
Abiomed acquired Breethe, a Baltimore-based startup, and its oxygenation device to expand its product portfolio in the respiratory space.
2020
Abiomed acquires Breethe
Abiomed acquired Breethe in late April 2020; the article says the deal's financial terms were not disclosed.
2020
Abiomed reports higher third-quarter earnings
Abiomed reported third-quarter profit of $69.22 million, up from $44.86 million in the prior-year quarter, with revenue rising 10.5% to $221.58 million.